# MP Biomedicals Asia Pacific Pte Ltd – FDA Inspection, Nov 7, 2016

Source: https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/ef8f77ac-cf01-4e60-9907-350dbaec8508
Source feed: FDA_Inspections

> FDA inspection 1002457 of MP Biomedicals Asia Pacific Pte Ltd, November 07, 2016. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002457
- Company Name: MP Biomedicals Asia Pacific Pte Ltd
- Inspection Date: 2016-11-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1265006 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/d5bda2f5-0d87-4694-ab4d-3f50a76794bf)
- [FDA Inspection 1077526 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/2da55fc1-c489-4d12-9439-cfaeeb984d09)
- [FDA Inspection 1029898 - 2017-07-13](https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/9eaf2846-f691-4829-9b12-89ec8c9ef454)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/mp-biomedicals-asia-pacific-pte-ltd/75e41e7a-d050-40c9-b78a-0aae42525974

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
